Catalyst Wire Dossier Catalyst Wire Dossier

Mimrylo

rusfertide
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Mimrylo. Get the full timeline:

Most recent: FDA Approves First Drug of Its Kind for Polycythemia Vera, a Rare Blood Disorder

See pricing